B Cells as a Therapeutic Target in Paediatric Rheumatic Disease

by Meredyth G. Ll Wilkinson, Meredyth G. Ll Wilkinson, Meredyth G. Ll Wilkinson, Elizabeth C. Rosser, Elizabeth C. Rosser, Elizabeth C. Rosser
Published 2019-02-01

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

by Meredyth G. Ll Wilkinson, Claire T. Deakin, Charalampia Papadopoulou, Despina Eleftheriou, Lucy R. Wedderburn
Published 2021-09-01

CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α

by Christopher J. M. Piper, Meredyth G. Ll. Wilkinson, Meredyth G. Ll. Wilkinson, Claire T. Deakin, Claire T. Deakin, Claire T. Deakin, Georg W. Otto, Georg W. Otto, Stefanie Dowle, Stefanie Dowle, Chantal L. Duurland, Stuart Adams, Emiliano Marasco, Elizabeth C. Rosser, Anna Radziszewska, Anna Radziszewska, Rita Carsetti, Yiannis Ioannou, Yiannis Ioannou, Philip L. Beales, Philip L. Beales, Daniel Kelberman, Daniel Kelberman, David A. Isenberg, David A. Isenberg, Claudia Mauri, Kiran Nistala, Lucy R. Wedderburn, Lucy R. Wedderburn, Lucy R. Wedderburn
Published 2018-06-01